skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Decreased sensitivity of early imaging with In-111 oxine-labeled leukocytes in detection of occult infection: concise communication

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5077659

Imaging with leukocytes labeled with indium-111 oxine is a sensitive technique for detecting sites of occult infection. Traditionally, imaging is performed 24 hr after injection. The authors undertook a prospective study of 35 patients (40 studies) with possible occult infection to see whether a 24-hr delay in imaging is really necessary. Patients were imaged at 1-4 hr and again at 24 hr after injection. The early images had a sensitivity of only 33%, compared with 95% for the 24-hr images. Of the seven studies that were positive on both early and delayed images, 71% had more intense uptake at 24 hr. There were no false-positive early images. It was concluded that imaging 1-4 hr after injection with In-111 oxine-labeled leukocytes has a low sensitivity for detecting occult infection. However, a positive early image is specific for a site of infection.

Research Organization:
Univ. of Utah Medical Center and Veterans Administration Medical Center, Salt Lake City
OSTI ID:
5077659
Journal Information:
J. Nucl. Med.; (United States), Vol. 25:3
Country of Publication:
United States
Language:
English

Similar Records

No difference in sensitivity for occult infection between tropolone- and oxine-labeled indium-111 leukocytes
Journal Article · Wed May 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States) · OSTI ID:5077659

No difference in sensitivity for occult infection between oxine and tropolone labeled In-111 leukocytes when imaged early
Conference · Sun Jan 01 00:00:00 EST 1984 · J. Nucl. Med.; (United States) · OSTI ID:5077659

Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis
Journal Article · Thu Mar 01 00:00:00 EST 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:5077659